Seastar Medical Holding revenue was $1.23M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $420.0k, up 129.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ICU annual revenue was $1.2M, with 814.1% growth year-over-year.
ICU past revenue growth
How has ICU's revenue growth performed historically?
Seastar Medical Holding (NASDAQ: ICU) reported Q4 2025 revenue of $420.00 thousand up 526.87% year over year. In the same quarter last year, Seastar Medical Holding's revenue was $67.00 thousand.
What was Seastar Medical Holding's revenue in 2025?
Seastar Medical Holding's annual revenue for the twelve months ending Dec 31, 2025 was $1.23 million, a 814.07% increase year over year.
How much does Seastar Medical Holding make in a day?
Based on Seastar Medical Holding annual revenue for the past five years, ICU makes an average of $750.14 per day.
What was Seastar Medical Holding's annual revenue growth in the past year?
As of Q2 2026, Seastar Medical Holding's revenue has grown 814.07% year over year. This is 314.91 percentage points higher than the US Biotechnology industry revenue growth rate of 499.16%. Seastar Medical Holding's revenue in the past year totaled $1.23 million.
How much does Seastar Medical Holding make in a year?
Seastar Medical Holding's revenue by year for the past five years is:
Seastar Medical Holding's revenue for the twelve months ending Dec 31, 2025 was $1.23 million, a 814.07% increase year over year.
Seastar Medical Holding's annual revenue for Dec 31, 2024 was $135.00 thousand, a Infinity% increase from 2023.
Seastar Medical Holding's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
Seastar Medical Holding's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Seastar Medical Holding's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.